Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.13%18.8814.1%$243.08m
SHPGShire PLC Sponsored ADR
-0.92%134.060.4%$206.82m
SAGESAGE Therapeutics, Inc.
-0.75%162.379.8%$109.73m
PRGOPerrigo Co. Plc
-0.11%89.556.6%$84.14m
ICPTIntercept Pharmaceuticals, Inc.
0.79%61.1222.0%$72.23m
MDCOMedicines Company
2.54%33.1622.1%$61.90m
JAZZJazz Pharmaceuticals Plc
1.23%145.762.2%$57.13m
MNKMallinckrodt Plc
0.36%16.8018.5%$52.82m
UTHRUnited Therapeutics Corporation
-0.87%134.9314.5%$52.29m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.26%131.017.6%$50.60m
CTLTCatalent Inc
1.19%43.382.6%$48.78m
ICLRICON Plc
1.01%115.014.1%$43.90m
CORTCorcept Therapeutics Incorporated.
2.70%15.985.5%$41.19m
PTLAPortola Pharmaceuticals, Inc.
-0.56%47.697.8%$39.94m
PBHPrestige Brands Holdings, Inc.
1.18%35.233.8%$39.63m

Company Profile

Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.